Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 312.38M P/E - EPS this Y -0.50% Ern Qtrly Grth -
Income -56.07M Forward P/E -5.21 EPS next Y 13.20% 50D Avg Chg 12.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 33.00%
Dividend N/A Price/Book 2.89 EPS next 5Y - 52W High Chg -34.00%
Recommedations 2.10 Quick Ratio 8.81 Shares Outstanding 29.65M 52W Low Chg 189.00%
Insider Own 29.17% ROA -37.42% Shares Float 19.11M Beta -0.61
Inst Own 32.51% ROE -61.81% Shares Shorted/Prior 3.02M/1.98M Price 10.68
Gross Margin - Profit Margin - Avg. Volume 118,643 Target Price 11.21
Oper. Margin - Earnings Date - Volume 52,517 Change 0.38%
About Immuneering Corporation

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.

Immuneering Corporation News
11/13/24 Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
10/16/24 IMRX Stock Up on FDA's Orphan Drug Tag for Pancreatic Cancer Drug
10/15/24 Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
10/14/24 Here's Why We're A Bit Worried About Immuneering's (NASDAQ:IMRX) Cash Burn Situation
09/16/24 IMRX Stock Soars on Upbeat Efficacy Data From Pancreatic Cancer Study
09/13/24 Why Is Nanocap Immuneering Stock Trading Higher On Friday?
09/12/24 Immuneering Announces Positive Initial Phase 2a Data Including Complete and Partial Responses with IMM-1-104 in Combination with Chemotherapy in First-Line Pancreatic Cancer Patients
08/29/24 Immuneering to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
08/28/24 Favourable Signals For Immuneering: Numerous Insiders Acquired Stock
08/06/24 Immuneering Reports Second Quarter 2024 Financial Results and Provides Business Updates
07/31/24 Immuneering Granted FDA Fast Track Designation for IMM-1-104 in First-line Pancreatic Cancer
05/29/24 Immuneering to Present at the Jefferies Global Healthcare Conference
05/07/24 Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
05/07/24 We Think Immuneering (NASDAQ:IMRX) Needs To Drive Business Growth Carefully
05/06/24 Immuneering Recognizes Melanoma Awareness Month
04/09/24 IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models
04/03/24 Immuneering to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03/27/24 Immuneering Announces First Patient Dosed in its Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations
05:41 AM Immuneering Director Acquires 7.5% More Stock
03/18/24 Immuneering (IMRX) Plummets 71% in One Week: Here's Why
IMRX Chatroom

User Image Wisegill Posted - 16 minutes ago

$IMRX … perhaps, approaching a nice boil…?

User Image Wisegill Posted - 1 hour ago

$IMRX … possibly simmering…?

User Image Siuolman58 Posted - 1 hour ago

$IMRX Spark it up!!!

User Image XQuise Posted - 22 hours ago

$IMRX

User Image Siuolman58 Posted - 1 day ago

$IMRX Shes gonna blow!!!

User Image Siuolman58 Posted - 1 day ago

$IMRX I smell news!!

User Image Wisegill Posted - 1 day ago

$IMRX something stirring…?

User Image ShoCap Posted - 2 days ago

$IMRX looks good 🥂

User Image wat92098 Posted - 2 days ago

$IMRX Results coming?

User Image ako13 Posted - 2 days ago

@ChartLaboratory_com $IMRX ? This did'nt aged well

User Image pump_then_dump Posted - 2 days ago

$IMRX this stock sucks

User Image pump_then_dump Posted - 3 days ago

$IMRX when price was 1.81 this morning why did it fill my order at 1.90????!?

User Image The_Platinum_Polyhedron Posted - 4 days ago

$ZONE One thing I love most about $ZONE is through all the superficial chop I don't have to worry about a run pull like I did with $IMRX & $MNTS.

User Image Kdog125 Posted - 5 days ago

$IMRX lmfao but down 9% today SMH

User Image wat92098 Posted - 5 days ago

$IMRX so, sold some yesterday, for a good profit, because we know they’re going to do this continually. Drag it down after good news. So, today it’s a bargain, until the next good news comes out

User Image Eruption Posted - 6 days ago

$IMRX always the same story. So manipulated. But there will be a payoff. To the manipulators, it pays every day. I'd say they are evil, but they are just good at playing the game, and I don't know how to play. Hopefully I'll win in the long term.

User Image Pinow Posted - 6 days ago

$IMRX this is ridiculous

User Image whaiting Posted - 6 days ago

$IMRX The stock continues to fall surprisingly.

User Image ChartLaboratory_com Posted - 6 days ago

🚀 Big moves in the market today with $PLBY, $NOVA, $IMRX, $GORV, and $ZCAR! 🔥 ✅ Watch for resistance at key levels and bullish patterns forming! 💡 💥 Targets set at $1.25 for $PLBY, $4.60 for $NOVA, and $2.50 for $IMRX. ⚡️Stay ahead of the trends with Chart Lab! 🎯 🔗 Join Chart Lab on Patreon for insights and updates! 📈 https://www.patreon.com/ChartLAB #stocks #stocktrading #investing #breakout #patreon #trading #stocksignals #market https://www.patreon.com/ChartLAB

User Image Rocket_Labs Posted - 6 days ago

$AKTS $IMRX $PMEC $CDTG $ZONE

User Image Stocksrockman Posted - 6 days ago

Boats and hoes in the $ZONE baby Black hoes White hoes Asian hoes And NAVAJOS Come get your slap on in the ZONE $AKTS and $IMRX finished the day green $CDTG and $pmec are very interesting

User Image Kobewins Posted - 6 days ago

$IMRX where are all the stock gurus who post predictions & charts once the stock explodes? This is the time to show how knowledgeable you are: Tell what the charts telling you now. Tell us your 1 week price prediction now. Why is it so quiet now? Then once this goes up 200% folks pop out with their so call « I told you so ». BLAH!😑

User Image Julylizanlol Posted - 1 week ago

BOLT.CN 🚀 huge PR incoming, loading up. 🚨 Stock alert shared across 3 Discord groups. The 2-for-1 split is complete. Trader interest is rising, with average volume up from 28k to 81k, and recent spikes hitting 259k - 800k. Something big is brewing! $IMRX $BKSY $OSCR

User Image mcrotary Posted - 1 week ago

$IMRX

User Image investrn23 Posted - 1 week ago

$IMRX

User Image Kdog125 Posted - 1 week ago

$IMRX Daily chart looking nice 👀

User Image JunkPost Posted - 1 week ago

$IMRX Someone is buying for sure

User Image TheWinningStock Posted - 1 week ago

$IMRX <<---CEO buying

User Image TheWinningStock Posted - 1 week ago

$IMRX

User Image DARKP00L Posted - 1 week ago

$IMRX ﹩2.05 - Needham Reiterates Buy on Immuneering, Maintains $15 Price Target #pennystock #stockmarket #lowfloat #stockstotrade #stockscanner #tradinginsights #NYSE #darkpools

Analyst Ratings
Needham Buy Sep 13, 24
Chardan Capital Buy Aug 7, 24
Needham Buy Aug 7, 24
Needham Buy May 8, 24
Needham Buy Apr 12, 24
Mizuho Buy Apr 2, 24
Jefferies Hold Mar 15, 24
Chardan Capital Buy Mar 15, 24
Needham Buy Mar 15, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Zeskind Benjamin J. PRESIDENT AND CEO PRESIDENT AND CEO Dec 22 Option 3.01 2,500 7,525 2,261,852 12/27/22
Bookman Michael GENERAL COUNSEL AND.. GENERAL COUNSEL AND SECRETARY May 17 Buy 4.88 1,000 4,880 2,402 05/18/22
KEATING LAURIE Director Director May 16 Buy 5 7,000 35,000 14,000 05/17/22
Amin Biren CFO, TREASURER CFO, TREASURER May 12 Buy 4.42 1,000 4,420 7,898 05/12/22
Zeskind Benjamin J. PRESIDENT AND CEO PRESIDENT AND CEO Apr 12 Option 3.01 2,000 6,020 2,259,352 04/14/22
Zeskind Benjamin J. PRESIDENT AND CEO PRESIDENT AND CEO Mar 23 Buy 8.02 3,000 24,060 2,257,352 03/24/22
Hall Brett Matthew CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Mar 23 Buy 7.91 1,050 8,306 330,134 03/23/22
Barrett Scott CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Mar 22 Buy 7.485 900 6,736 7,563 03/22/22
Feinberg Peter Director Director Mar 15 Buy 6.75 6,667 45,002 11,766 03/16/22
BERMAN ANN E Director Director Mar 15 Buy 6.40 6,000 38,400 9,500 03/15/22
Zeskind Benjamin J. PRESIDENT AND CEO PRESIDENT AND CEO Feb 28 Option 3.01 2,000 6,020 2,254,352 03/01/22